These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12912773)

  • 21. The 5-HT6 receptor as a target for developing novel antiobesity drugs.
    Heal D; Gosden J; Smith S
    Int Rev Neurobiol; 2011; 96():73-109. PubMed ID: 21329785
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.
    Shi Y; Burn P
    Nat Rev Drug Discov; 2004 Aug; 3(8):695-710. PubMed ID: 15286736
    [No Abstract]   [Full Text] [Related]  

  • 23. Medications as adjunct therapy for weight loss: approved and off-label agents in use.
    Moyers SB
    J Am Diet Assoc; 2005 Jun; 105(6):948-59. PubMed ID: 15942547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ghrelin--a novel generation of anti-obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues.
    Chollet C; Meyer K; Beck-Sickinger AG
    J Pept Sci; 2009 Nov; 15(11):711-30. PubMed ID: 19787814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The obesity epidemic: pharmacological challenges.
    Bloom SR; Kuhajda FP; Laher I; Pi-Sunyer X; Ronnett GV; Tan TM; Weigle DS
    Mol Interv; 2008 Apr; 8(2):82-98. PubMed ID: 18403653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The discovery of taranabant, a selective cannabinoid-1 receptor inverse agonist for the treatment of obesity.
    Hagmann WK
    Arch Pharm (Weinheim); 2008 Jul; 341(7):405-11. PubMed ID: 18574849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Novel anti-obesity drugs].
    Tripp B; Ludvik B
    Acta Med Austriaca; 2004; 31(4):133-8. PubMed ID: 15732249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National trends in the use and costs of anti-obesity medications in England 1998-2005.
    Srishanmuganathan J; Patel H; Car J; Majeed A
    J Public Health (Oxf); 2007 Jun; 29(2):199-202. PubMed ID: 17494061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone secretagogue receptor antagonists as anti-obesity therapies? Still an open question.
    Zhao H; Liu G
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):509-15. PubMed ID: 16889233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Xenical--a modern perspective drug for the treatment of obesity (review)].
    Mkrtumian AM; Biriukova EV
    Ter Arkh; 2007; 79(10):35-9. PubMed ID: 18154143
    [No Abstract]   [Full Text] [Related]  

  • 31. NPY and energy homeostasis: an opportunity for novel anti-obesity therapies.
    MacNeil DJ; Kanatani A
    EXS; 2006; (95):143-56. PubMed ID: 16383004
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach.
    Freemark M
    Diabetes Care; 2007 Feb; 30(2):395-402. PubMed ID: 17259519
    [No Abstract]   [Full Text] [Related]  

  • 33. ABC of obesity. Management: part II--drugs.
    Lean M; Finer N
    BMJ; 2006 Oct; 333(7572):794-7. PubMed ID: 17038738
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel pharmacotherapies for obesity poised to enter market.
    Jones D
    Nat Rev Drug Discov; 2009 Nov; 8(11):833-4. PubMed ID: 19876031
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacologic agents for the treatment of obesity.
    Mathys M
    Clin Geriatr Med; 2005 Nov; 21(4):735-46, vii. PubMed ID: 16182086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacological treatment of obesity and syndrome X].
    Thissen JP
    J Pharm Belg; 2001; 56(2):45-50. PubMed ID: 11396351
    [No Abstract]   [Full Text] [Related]  

  • 37. S 23521 decreases food intake and body weight gain in diet-induced obese rats.
    Claret M; Corominola H; Canals I; Nadal B; Chavanieu A; Pfeiffer B; Renard P; Gorostiaga C; Delagrange P; Grassy G; Gomis R
    Obes Res; 2004 Oct; 12(10):1596-603. PubMed ID: 15536223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on the pharmacological treatment of obesity.
    Schnee DM; Zaiken K; McCloskey WW
    Curr Med Res Opin; 2006 Aug; 22(8):1463-74. PubMed ID: 16870072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug therapy of obesity--from bitter experiences to future possibilities].
    Rössner S
    Lakartidningen; 2000 Apr; 97(14):1726-8. PubMed ID: 10815399
    [No Abstract]   [Full Text] [Related]  

  • 40. [Primary health care fails when it comes to obesity drug therapy. There is a lack of structured, aimed care].
    Kjellström T
    Lakartidningen; 2010 Mar 31-Apr 13; 107(13-14):895. PubMed ID: 20432861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.